Deccan Health Care Intrinsic Value
Deccan Health Care (DECCAN) median intrinsic value is ₹20.87 from 7 valuation models (range ₹9–₹35), vs current price ₹11.75 — +77.6% upside (Trading Below Calculated Value), margin of safety 43.7%. For current market price and key ratios, visit DECCAN stock overview.
DECCAN Valuation Methods Summary — DCF, Graham Number & P/E
Deccan Health Care intrinsic value across 7 models vs current price ₹11.75 — upside/downside and value range per method. Browse DECCAN quarterly financials for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹17.76 | ₹14.21 - ₹21.31 | +51.1% | EPS: ₹1.48, Sector P/E: 12x |
| Book Value Method | asset | ₹29.38 | ₹26.44 - ₹32.32 | +150.0% | Book Value/Share: ₹46.09, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹23.50 | ₹21.15 - ₹25.85 | +100.0% | Revenue/Share: ₹36.52, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹20.87 | ₹18.78 - ₹22.96 | +77.6% | EBITDA: ₹8.00Cr, EV/EBITDA: 6x |
| PEG Ratio Method | growth | ₹9.47 | ₹8.52 - ₹10.42 | -19.4% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹12.20 | ₹10.98 - ₹13.42 | +3.8% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| Graham Defensive Method | conservative | ₹35.25 | ₹31.73 - ₹38.78 | +200.0% | EPS: ₹1.48, BVPS: ₹46.09 |
DECCAN Intrinsic Value vs Market Price — All Valuation Models
Deccan Health Care fair value range ₹9–₹35 vs current market price ₹11.75 across 7 valuation models. Compare with Deccan Health Care value estimation to assess whether the stock is under or overvalued.
DECCAN Intrinsic Value Analysis — Undervalued or Overvalued?
Deccan Health Care median intrinsic value ₹20.87, current price ₹11.75 — Trading Below Calculated Value by 77.6%, margin of safety 43.7%.
What is the intrinsic value of DECCAN?
Based on our comprehensive analysis using 7 different valuation methods, the estimated intrinsic value of Deccan Health Care (DECCAN) is ₹20.87 (median value). With the current market price of ₹11.75, this represents a +77.6% variance from our estimated fair value.
The valuation range spans from ₹9.47 to ₹35.25, indicating ₹9.47 - ₹35.25.
Is DECCAN undervalued or overvalued?
Based on our multi-method analysis, Deccan Health Care (DECCAN) appears to be trading below calculated value by approximately 77.6%.
DECCAN Financial Health — Key Ratios vs Industry Benchmarks
Deccan Health Care financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 35.33 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 3.8% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 8.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.67x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
DECCAN Cash Flow Quality — Operating & Free Cash Flow
Deccan Health Care operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-6 Cr | ₹-6 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-13 Cr | ₹-13 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-7 Cr | ₹-7 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |